ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Preclinical Toxicology Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-11D18277
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Preclinical Toxicology Service Market Research Report 2024
BUY CHAPTERS

Global Preclinical Toxicology Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11D18277
Report
October 2025
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River Laboratories
LabCorp
Eurofins Scientific
PRA Health Sciences
Envigo
WuXi AppTec
ICON
Syneos Health
Toxikon
Intertek
Scantox
Biosciences Laboratories

Preclinical Toxicology Service Market

The global Preclinical Toxicology Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Preclinical Toxicology Service is one of the key steps in drug development to evaluate the safety, toxicity and potential adverse reactions of candidate drugs or treatment options. These services are usually performed before the drug enters clinical trials and cover acute, subchronic and chronic toxicity studies, as well as genotoxicity, carcinogenicity and reproductive toxicity assessments. The results of preclinical toxicology studies can help pharmaceutical companies and research institutions understand the safety characteristics of candidate drugs and decide whether to advance clinical trials.
From a downstream perspective, Biopharmaceutical Company accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Preclinical Toxicology Service leading manufacturers including Charles River Laboratories, Labcorp, Eurofins Scientific, PRA Health Sciences, Envigo, WuXi AppTec, ICON, Syneos Health, Biosciences Laboratories, Toxikon, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River Laboratories leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Preclinical Toxicology Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Preclinical Toxicology Service Market Report

Report Metric Details
Report Name Preclinical Toxicology Service Market
Segment by Type
  • Genetic Toxicity Testing
  • Reproductive Toxicity Testing
  • Immunotoxicity Testing
  • Others
Segment by Application
  • Biopharmaceutical Company
  • Research Laboratory
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River Laboratories, Labcorp, Eurofins Scientific, PRA Health Sciences, Envigo, WuXi AppTec, ICON, Syneos Health, Biosciences Laboratories, Toxikon, Intertek, Scantox
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Preclinical Toxicology Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Preclinical Toxicology Service Market report?

Ans: The main players in the Preclinical Toxicology Service Market are Charles River Laboratories, Labcorp, Eurofins Scientific, PRA Health Sciences, Envigo, WuXi AppTec, ICON, Syneos Health, Biosciences Laboratories, Toxikon, Intertek, Scantox

What are the Application segmentation covered in the Preclinical Toxicology Service Market report?

Ans: The Applications covered in the Preclinical Toxicology Service Market report are Biopharmaceutical Company, Research Laboratory, Others

What are the Type segmentation covered in the Preclinical Toxicology Service Market report?

Ans: The Types covered in the Preclinical Toxicology Service Market report are Genetic Toxicity Testing, Reproductive Toxicity Testing, Immunotoxicity Testing, Others

1 Study Coverage
1.1 Introduction to Preclinical Toxicology Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Preclinical Toxicology Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Genetic Toxicity Testing
1.2.3 Reproductive Toxicity Testing
1.2.4 Immunotoxicity Testing
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Preclinical Toxicology Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Company
1.3.3 Research Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Preclinical Toxicology Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Preclinical Toxicology Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Preclinical Toxicology Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Preclinical Toxicology Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Genetic Toxicity Testing Market Size by Players
3.3.2 Reproductive Toxicity Testing Market Size by Players
3.3.3 Immunotoxicity Testing Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Preclinical Toxicology Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Preclinical Toxicology Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Preclinical Toxicology Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Preclinical Toxicology Service Market Size by Type (2020-2031)
6.4 North America Preclinical Toxicology Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Preclinical Toxicology Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Preclinical Toxicology Service Market Size by Type (2020-2031)
7.4 Europe Preclinical Toxicology Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Preclinical Toxicology Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Preclinical Toxicology Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Preclinical Toxicology Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Preclinical Toxicology Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Preclinical Toxicology Service Market Size by Type (2020-2031)
9.4 Central and South America Preclinical Toxicology Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Preclinical Toxicology Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Preclinical Toxicology Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Preclinical Toxicology Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Preclinical Toxicology Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Corporation Information
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Preclinical Toxicology Service Product Features and Attributes
11.1.4 Charles River Laboratories Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Laboratories Preclinical Toxicology Service Revenue by Product in 2024
11.1.6 Charles River Laboratories Preclinical Toxicology Service Revenue by Application in 2024
11.1.7 Charles River Laboratories Preclinical Toxicology Service Revenue by Geographic Area in 2024
11.1.8 Charles River Laboratories Preclinical Toxicology Service SWOT Analysis
11.1.9 Charles River Laboratories Recent Developments
11.2 Labcorp
11.2.1 Labcorp Corporation Information
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Preclinical Toxicology Service Product Features and Attributes
11.2.4 Labcorp Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.2.5 Labcorp Preclinical Toxicology Service Revenue by Product in 2024
11.2.6 Labcorp Preclinical Toxicology Service Revenue by Application in 2024
11.2.7 Labcorp Preclinical Toxicology Service Revenue by Geographic Area in 2024
11.2.8 Labcorp Preclinical Toxicology Service SWOT Analysis
11.2.9 Labcorp Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Preclinical Toxicology Service Product Features and Attributes
11.3.4 Eurofins Scientific Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific Preclinical Toxicology Service Revenue by Product in 2024
11.3.6 Eurofins Scientific Preclinical Toxicology Service Revenue by Application in 2024
11.3.7 Eurofins Scientific Preclinical Toxicology Service Revenue by Geographic Area in 2024
11.3.8 Eurofins Scientific Preclinical Toxicology Service SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Corporation Information
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Preclinical Toxicology Service Product Features and Attributes
11.4.4 PRA Health Sciences Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.4.5 PRA Health Sciences Preclinical Toxicology Service Revenue by Product in 2024
11.4.6 PRA Health Sciences Preclinical Toxicology Service Revenue by Application in 2024
11.4.7 PRA Health Sciences Preclinical Toxicology Service Revenue by Geographic Area in 2024
11.4.8 PRA Health Sciences Preclinical Toxicology Service SWOT Analysis
11.4.9 PRA Health Sciences Recent Developments
11.5 Envigo
11.5.1 Envigo Corporation Information
11.5.2 Envigo Business Overview
11.5.3 Envigo Preclinical Toxicology Service Product Features and Attributes
11.5.4 Envigo Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.5.5 Envigo Preclinical Toxicology Service Revenue by Product in 2024
11.5.6 Envigo Preclinical Toxicology Service Revenue by Application in 2024
11.5.7 Envigo Preclinical Toxicology Service Revenue by Geographic Area in 2024
11.5.8 Envigo Preclinical Toxicology Service SWOT Analysis
11.5.9 Envigo Recent Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Corporation Information
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Preclinical Toxicology Service Product Features and Attributes
11.6.4 WuXi AppTec Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.6.5 WuXi AppTec Recent Developments
11.7 ICON
11.7.1 ICON Corporation Information
11.7.2 ICON Business Overview
11.7.3 ICON Preclinical Toxicology Service Product Features and Attributes
11.7.4 ICON Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.7.5 ICON Recent Developments
11.8 Syneos Health
11.8.1 Syneos Health Corporation Information
11.8.2 Syneos Health Business Overview
11.8.3 Syneos Health Preclinical Toxicology Service Product Features and Attributes
11.8.4 Syneos Health Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.8.5 Syneos Health Recent Developments
11.9 Biosciences Laboratories
11.9.1 Biosciences Laboratories Corporation Information
11.9.2 Biosciences Laboratories Business Overview
11.9.3 Biosciences Laboratories Preclinical Toxicology Service Product Features and Attributes
11.9.4 Biosciences Laboratories Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.9.5 Biosciences Laboratories Recent Developments
11.10 Toxikon
11.10.1 Toxikon Corporation Information
11.10.2 Toxikon Business Overview
11.10.3 Toxikon Preclinical Toxicology Service Product Features and Attributes
11.10.4 Toxikon Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Intertek
11.11.1 Intertek Corporation Information
11.11.2 Intertek Business Overview
11.11.3 Intertek Preclinical Toxicology Service Product Features and Attributes
11.11.4 Intertek Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.11.5 Intertek Recent Developments
11.12 Scantox
11.12.1 Scantox Corporation Information
11.12.2 Scantox Business Overview
11.12.3 Scantox Preclinical Toxicology Service Product Features and Attributes
11.12.4 Scantox Preclinical Toxicology Service Revenue and Gross Margin (2020-2025)
11.12.5 Scantox Recent Developments
12 Preclinical Toxicology ServiceIndustry Chain Analysis
12.1 Preclinical Toxicology Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Preclinical Toxicology Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Preclinical Toxicology Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Charles River Laboratories
LabCorp
Eurofins Scientific
PRA Health Sciences
Envigo
WuXi AppTec
ICON
Syneos Health
Toxikon
Intertek
Scantox
Biosciences Laboratories
List of Tables
 Table 1. Global Preclinical Toxicology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Preclinical Toxicology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Preclinical Toxicology Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Preclinical Toxicology Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Preclinical Toxicology Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Preclinical Toxicology Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Preclinical Toxicology Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Toxicology Service as of 2024)
 Table 11. Global Preclinical Toxicology Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Preclinical Toxicology Service Companies Headquarters
 Table 13. Global Preclinical Toxicology Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Preclinical Toxicology Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Preclinical Toxicology Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Preclinical Toxicology Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Preclinical Toxicology Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Preclinical Toxicology Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Preclinical Toxicology Service Growth Accelerators and Market Barriers
 Table 25. North America Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Preclinical Toxicology Service Growth Accelerators and Market Barriers
 Table 27. Europe Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Preclinical Toxicology Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Preclinical Toxicology Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Preclinical Toxicology Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Preclinical Toxicology Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Charles River Laboratories Corporation Information
 Table 35. Charles River Laboratories Description and Major Businesses
 Table 36. Charles River Laboratories Product Features and Attributes
 Table 37. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Charles River Laboratories Revenue Proportion by Product in 2024
 Table 39. Charles River Laboratories Revenue Proportion by Application in 2024
 Table 40. Charles River Laboratories Revenue Proportion by Geographic Area in 2024
 Table 41. Charles River Laboratories Preclinical Toxicology Service SWOT Analysis
 Table 42. Charles River Laboratories Recent Developments
 Table 43. Labcorp Corporation Information
 Table 44. Labcorp Description and Major Businesses
 Table 45. Labcorp Product Features and Attributes
 Table 46. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Labcorp Revenue Proportion by Product in 2024
 Table 48. Labcorp Revenue Proportion by Application in 2024
 Table 49. Labcorp Revenue Proportion by Geographic Area in 2024
 Table 50. Labcorp Preclinical Toxicology Service SWOT Analysis
 Table 51. Labcorp Recent Developments
 Table 52. Eurofins Scientific Corporation Information
 Table 53. Eurofins Scientific Description and Major Businesses
 Table 54. Eurofins Scientific Product Features and Attributes
 Table 55. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Eurofins Scientific Revenue Proportion by Product in 2024
 Table 57. Eurofins Scientific Revenue Proportion by Application in 2024
 Table 58. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
 Table 59. Eurofins Scientific Preclinical Toxicology Service SWOT Analysis
 Table 60. Eurofins Scientific Recent Developments
 Table 61. PRA Health Sciences Corporation Information
 Table 62. PRA Health Sciences Description and Major Businesses
 Table 63. PRA Health Sciences Product Features and Attributes
 Table 64. PRA Health Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. PRA Health Sciences Revenue Proportion by Product in 2024
 Table 66. PRA Health Sciences Revenue Proportion by Application in 2024
 Table 67. PRA Health Sciences Revenue Proportion by Geographic Area in 2024
 Table 68. PRA Health Sciences Preclinical Toxicology Service SWOT Analysis
 Table 69. PRA Health Sciences Recent Developments
 Table 70. Envigo Corporation Information
 Table 71. Envigo Description and Major Businesses
 Table 72. Envigo Product Features and Attributes
 Table 73. Envigo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Envigo Revenue Proportion by Product in 2024
 Table 75. Envigo Revenue Proportion by Application in 2024
 Table 76. Envigo Revenue Proportion by Geographic Area in 2024
 Table 77. Envigo Preclinical Toxicology Service SWOT Analysis
 Table 78. Envigo Recent Developments
 Table 79. WuXi AppTec Corporation Information
 Table 80. WuXi AppTec Description and Major Businesses
 Table 81. WuXi AppTec Product Features and Attributes
 Table 82. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. WuXi AppTec Recent Developments
 Table 84. ICON Corporation Information
 Table 85. ICON Description and Major Businesses
 Table 86. ICON Product Features and Attributes
 Table 87. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. ICON Recent Developments
 Table 89. Syneos Health Corporation Information
 Table 90. Syneos Health Description and Major Businesses
 Table 91. Syneos Health Product Features and Attributes
 Table 92. Syneos Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Syneos Health Recent Developments
 Table 94. Biosciences Laboratories Corporation Information
 Table 95. Biosciences Laboratories Description and Major Businesses
 Table 96. Biosciences Laboratories Product Features and Attributes
 Table 97. Biosciences Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Biosciences Laboratories Recent Developments
 Table 99. Toxikon Corporation Information
 Table 100. Toxikon Description and Major Businesses
 Table 101. Toxikon Product Features and Attributes
 Table 102. Toxikon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Toxikon Recent Developments
 Table 104. Intertek Corporation Information
 Table 105. Intertek Description and Major Businesses
 Table 106. Intertek Product Features and Attributes
 Table 107. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Intertek Recent Developments
 Table 109. Scantox Corporation Information
 Table 110. Scantox Description and Major Businesses
 Table 111. Scantox Product Features and Attributes
 Table 112. Scantox Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Scantox Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Preclinical Toxicology Service Product Picture
 Figure 2. Global Preclinical Toxicology Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Genetic Toxicity Testing Product Picture
 Figure 4. Reproductive Toxicity Testing Product Picture
 Figure 5. Immunotoxicity Testing Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Preclinical Toxicology Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Biopharmaceutical Company
 Figure 9. Research Laboratory
 Figure 10. Others
 Figure 11. Preclinical Toxicology Service Report Years Considered
 Figure 12. Global Preclinical Toxicology Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Preclinical Toxicology Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Preclinical Toxicology Service Revenue Market Share by Region (2020-2031)
 Figure 16. Global Preclinical Toxicology Service Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Genetic Toxicity Testing Revenue Market Share by Player in 2024
 Figure 19. Reproductive Toxicity Testing Revenue Market Share by Player in 2024
 Figure 20. Immunotoxicity Testing Revenue Market Share by Player in 2024
 Figure 21. Others Revenue Market Share by Player in 2024
 Figure 22. Global Preclinical Toxicology Service Revenue Market Share by Type (2020-2031)
 Figure 23. Global Preclinical Toxicology Service Revenue Market Share by Application (2020-2031)
 Figure 24. North America Preclinical Toxicology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players Preclinical Toxicology Service Revenue (US$ Million) in 2024
 Figure 26. North America Preclinical Toxicology Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America Preclinical Toxicology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe Preclinical Toxicology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players Preclinical Toxicology Service Revenue (US$ Million) in 2024
 Figure 33. Europe Preclinical Toxicology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe Preclinical Toxicology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 36. France Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Preclinical Toxicology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players Preclinical Toxicology Service Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific Preclinical Toxicology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific Preclinical Toxicology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 48. India Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore Preclinical Toxicology Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America Preclinical Toxicology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players Preclinical Toxicology Service Revenue (US$ Million) in 2024
 Figure 56. Central and South America Preclinical Toxicology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America Preclinical Toxicology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa Preclinical Toxicology Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players Preclinical Toxicology Service Revenue (US$ Million) in 2024
 Figure 62. South America Preclinical Toxicology Service Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa Preclinical Toxicology Service Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa Preclinical Toxicology Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Preclinical Toxicology Service Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Preclinical Toxicology Testing Service Market Research Report 2024
Global Preclinical Research Service Market Research Report 2024
Global Nonclinical Safety Assessment Service Market Research Report 2025
Global Clinical Chemistry Devises for Laboratory Animal Models Market Insights Forecast to 2030
Oncology Based Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Toxicological Testing Market Research Report 2024
Preclinical Oncology CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Based In vitro CRO Market Research Report 2024
Global Preclinical Testing Service Market Research Report 2025
Global Pre Clinical Chemistry Testing Device for Laboratory Animal Models Market Insights Forecast to 2030
Global Cytotoxicity Testing Services Market Research Report 2025
Global Infusion Toxicology Services Market Research Report 2024
Global Computational Toxicology Service Market Research Report 2024
Global Oncology Based In vivo CRO Market Research Report 2024
Global Toxicological Risk Assessment Service Market Research Report 2024
Global Drug Safety Testing Market Research Report 2025
Global Toxicological Services Market Research Report 2024
Global Pre Clinical CROs Services Market Research Report 2024
Global Toxicology Laboratories Market Insights Forecast to 2030
Global Preclinical Capsule Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions